文献速递脊柱关节炎其他结缔组织病

银屑病关节炎中IL-23皮肤与关节表达谱分析:理解IL-23抑制剂临床应答的新视角

IL-23 skin and joint profiling in psoriatic arthritis: novel perspectives in understanding clinical responses to IL-23 inhibitors.
PubMed 文献 · Ann Rheum Dis · 2020-11-26

结果显示皮肤应答倾向乌司奴单抗、关节应答倾向抗TNF;滑膜IL-23轴表达高度异质,且与高级别滑膜炎相关,常规临床指标无法区分。

要点

  • 银屑病关节炎滑膜IL-23轴表达较配对皮肤更异质。
  • 滑膜IL-23表达与高级别滑膜炎相关,常规指标难区分。
  • 皮肤应答倾向乌司奴单抗,关节应答倾向抗TNF。

核心结论

  • 活动性银屑病关节炎患者滑膜组织IL-23轴表达较配对皮肤更异质。
  • 滑膜分子病理可能帮助识别对IL-23抑制剂应答概率更高的临床难以区分患者。

研究设计与样本

  • 生物制剂初治者接受抗TNF,抗TNF应答不足者接受乌司奴单抗。
  • 治疗前取滑膜及配对皮损/非皮损皮肤活检,实时PCR检测80个炎症相关基因,免疫组化检测IL-23p40/IL-23p19/IL-23R蛋白。

主要发现

  • 主要终点(治疗后16周)皮肤应答倾向乌司奴单抗,关节应答倾向抗TNF。
  • 主成分分析显示滑膜组织基因表达与配对皮肤明显分离聚类。
  • IL12B、IL23A、IL23R在皮损皮肤中均匀表达,在配对滑膜组织中表达极异质。
  • 滑膜IL-23转录/蛋白表达与高级别滑膜炎患者强相关,但常规临床指标无法区分这些患者。

关键数值与推荐

  • 主要终点为治疗后16周。
  • 分子分析覆盖80个炎症相关基因。
  • 蛋白检测包括IL-23p40、IL-23p19、IL-23R。

临床怎么用

  • 对临床难以区分的活动性银屑病关节炎患者,滑膜分子病理(尤其IL-23轴)可能辅助预判IL-23抑制剂应答概率。
  • 皮肤与关节对IL-23抑制剂和抗TNF的应答倾向不同,提示需分别评估皮肤与关节结局。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the relationship between synovial versus skin transcriptional/histological profiles in patients with active psoriatic arthritis (PsA) and explore mechanistic links between diseased tissue pathology and clinical outcomes. METHODS: Twenty-seven active PsA patients were enrolled in an observational/open-label study and underwent biopsies of synovium and paired lesional/non-lesional skin before starting anti-tumour necrosis factor (TNF) (if biologic-naïve) or ustekinumab (if anti-TNF inadequate responders). Molecular analysis of 80-inflammation-related genes and protein levels for interleukin (IL)-23p40/IL-23p19/IL-23R were assessed by real-time-PCR and immunohistochemistry, respectively. RESULTS: At baseline, all patients had persistent active disease as per inclusion criteria. At primary end-point (16-weeks post-treatment), skin responses favoured ustekinumab, while joint responses favoured anti-TNF therapies. Principal component analysis revealed distinct clustering of synovial tissue gene expression away from the matched skin. While IL12B, IL23A and IL23R were homogeneously expressed in lesional skin, their expression was extremely heterogeneous in paired synovial tissues. Here, IL-23 transcriptomic/protein expression was strongly linked to patients with high-grade synovitis who, however, were not distinguishable by conventional clinimetric measures. CONCLUSIONS: PsA synovial tissue shows a heterogeneous IL-23 axis profile when compared with matched skin. Synovial molecular pathology may help to identify among clinically indistinguishable patients those with a greater probability of responding to IL-23 inhibitors.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Nerviani A, Boutet MA, Tan WSG, et al. IL-23 skin and joint profiling in psoriatic arthritis: novel perspectives in understanding clinical responses to IL-23 inhibitors. Ann Rheum Dis. 2020. PMID: 33243781. doi:10.1136/annrheumdis-2020-218186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。